Gastrointestinal Endoscopic Devices Market Size Set to Reach USD 16.84 Billion by 2032 – SNS Insider

According to Research by SNS Insider, the Gastrointestinal Endoscopic Devices Market growth is Driven by Advancements in minimally invasive procedures and increasing prevalence of gastrointestinal disorders.

Austin, July 01, 2025 (GLOBE NEWSWIRE) — Gastrointestinal Endoscopic Devices Market Size & Growth Analysis:

The Gastrointestinal Endoscopic Devices Market was valued at USD 10.78 billion in 2023 and is projected to reach USD 16.84 billion by 2032, growing at a CAGR of 5.11% over the forecast period 2024-2032. This growth is primarily attributed to technological advancements in endoscopic procedures and a rising incidence of gastrointestinal disorders globally.

Get a Sample Report of Gastrointestinal Endoscopic Devices Market@ https://www.snsinsider.com/sample-request/5880

Market Overview

The rising trend towards minimally invasive procedures has driven the market for gastrointestinal endoscopic devices strongly. The advantages of these procedures, including decreased recovery periods, less risk involved in surgery, and shorter stays in hospitals, have made them popular. Furthermore, the increasing incidence of gastrointestinal disorders, such as colorectal cancer and inflammatory bowel disease, has increased the demand for advanced diagnostic and therapeutic endoscopic devices.

Technological advancements have also increased the efficiency of endoscopic instruments, making diagnostics and treatment more accurate and more effective. Integration of artificial intelligence and robotic systems in endoscopy has enhanced procedure accuracy and patient outcomes. Additionally, growing healthcare spend and supportive government policy in favor of early detection of disease for market growth drive the market.

Major Players Analysis Listed in this Report are:

• Olympus Corporation – EVIS X1 Endoscopy System, GIF-HQ190 Gastroscope, CF-HQ190L/I Colonoscope
• Boston Scientific Corporation – SpyGlass DS Direct Visualization System, Resolution 360 Clip, Expect Slimline Needle
• Medtronic – PillCam SB3 Capsule Endoscopy System, Barrx Radiofrequency Ablation System, Emprint Ablation System
• Johnson & Johnson Services, Inc. (Ethicon Inc.) – ENSEAL X1 Large Jaw Tissue Sealer, STRATAFIX Knotless Tissue Control Devices
• KARL STORZ SE & Co. KG – C-MAC Video Gastroscope, Telepack+ Endoscopic Imaging System
• Fujifilm Holdings Corporation – ELUXEO Video Endoscopy System, EG-760Z Gastroscope, EC-760R Colonoscope
• Stryker – 1688 AIM 4K Endoscopic Camera, SPY Portable Handheld Imaging System
• HOYA Corporation (PENTAX Medical) – i10 Series Video Endoscopes, DEFINA Endoscopy System, MagniView Gastroscope
• Smith+Nephew – Dyonics RF System (used in GI applications for hemostasis)
• Cook Medical – Hemospray Endoscopic Hemostasis System, Evolution Stent System, Fusion OMNI ERCP Cannula
• CONMED Corporation – Beamer Endoscopic Electrosurgical Unit, TruPass Biopsy Forceps
• Ambu A/S – aScope Gastro Disposable Endoscope, aScope Colon Disposable Endoscope
• Richard Wolf GmbH – ENDOCAM Logic 4K Endoscopy System, ERAGONmodular Laparoscopic Instruments
• STERIS plc – Celerity Endoscope Processing System, VaproSure Sterilization System

Gastrointestinal Endoscopic Devices Market Report Scope

Report Attributes	Details
Market Size in 2023	US$ 10.78 billion
Market Size by 2032	US$ 16.84 billion
CAGR	CAGR of 5.11% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Regional Analysis	North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)

Segment Analysis

By Type:

Flexible gastrointestinal endoscopes dominated the market in 2023, with a share of 49.2% of the total. This is because they are versatile in diagnosing and treating various gastrointestinal diseases, providing real-time visualization and therapeutic interventions. The fact that they can carry out complicated procedures with minimal invasiveness has cemented their place in clinical practice.

Disposable gastrointestinal endoscopes are seeing the maximum growth in the market. This growth is fueled by growing infection control concerns and patient safety. Single-use endoscopes avoid cross-contamination risk, minimize the necessity for complicated sterilization procedures, and improve operations efficiency, making them a preferred choice for healthcare professionals.

By End Use:

Outpatient facilities were the market leaders in 2023, with a 51.6% share. The trend toward outpatient facilities is driven by the need for affordable and convenient healthcare. Improvements in endoscopic technology have made it possible for intricate procedures to be performed safely in outpatient facilities, taking the pressure off hospitals and improving patient satisfaction.

The hospital industry is also anticipated to see tremendous growth in the years to come. Hospitals continue to invest in state-of-the-art endoscopic devices to handle complex and emergency situations. The complete care capacity and presence of specialist medical practitioners in hospitals make them essential deliverers of endoscopic procedures.

For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ https://www.snsinsider.com/request-analyst/5880

Gastrointestinal Endoscopic Devices Market Segmentation

By Type

• Rigid Gastrointestinal Endoscopes
  • Gastroscope (Upper GI Endoscope)
  • Enteroscope
  • Sigmoidoscope
  • Duodenoscope
• Flexible Gastrointestinal Endoscopes
  • Gastroscope (Upper GI Endoscope)
  • Enteroscope
  • Sigmoidoscope
  • Duodenoscope
  • Colonoscope
• Disposable Gastrointestinal Endoscopes
  • Gastroscope (Upper GI Endoscope)
  • Enteroscope
  • Sigmoidoscope
  • Duodenoscope
  • Colonoscope

By End Use

• Hospitals
• Outpatient Facilities

Regional Analysis

North America remained the largest region in the gastrointestinal endoscopic device market globally in 2023, with 32.5% of the total revenue share. This regional superiority is caused by well-established healthcare infrastructure, prevalence of GI disorders, and accelerated uptake of newer technologies. Dominance in key players’ presence and appropriate reimbursement policies strengthens the market for the region even further.

The Asia-Pacific region is forecasted to have the highest growth. The drivers for this strong growth include rising healthcare spending, escalating awareness of gastrointestinal health, and an aging geriatric population. India and China are both major investors in healthcare infrastructure, which has led to heightened use of endoscopic procedures.

Recent Developments

• In April 2024, Fujifilm unveiled its latest endoscopic device, Tracmotion, at Endocon 2024 in Delhi. This innovative device enhances the Endoscopic Submucosal Dissection (ESD) process, facilitating more precise and effective treatment of gastrointestinal lesions.
• In January 2024, AnX Robotica received de novo clearance from the FDA for its AI-assisted endoscopy device, NaviCam ProScan. This tool utilizes convolutional neural networks to distinguish between healthy tissue and abnormal lesions, improving diagnostic accuracy.
• In December 2023, Medtronic expanded its partnership with Cosmo Intelligent Medical Devices, investing USD 100 million to enhance the GI Genius platform. This AI-driven system assists in identifying potential lesions during colonoscopies, improving detection capabilities.
• In November 2023, Olympus introduced the EVIS X1, a next-generation endoscopy system designed to improve outcomes for gastrointestinal disorders. The system offers advanced imaging capabilities, aiding in early disease detection.
• In October 2023, Pentax Medical launched the IMAGINA endoscopy system, offering high-definition imaging and enhanced ergonomics. This system aims to provide cost-effective solutions for endoscopic procedures.
• In September 2023, Boston Scientific launched the EXALT Model D, the first single-use duodenoscope approved by the FDA. This device addresses infection risks associated with reusable scopes, enhancing patient safety.

Statistical Insights and Trends

• The global prevalence of gastrointestinal disorders has been rising, with colorectal cancer being one of the leading causes of cancer-related deaths. Early detection through endoscopic procedures is crucial in reducing mortality rates.
• North America and Europe have historically performed the highest number of endoscopic procedures. However, Asia-Pacific is expected to witness the most significant increase in procedure volumes due to improving healthcare infrastructure and growing awareness.
• North America leads in healthcare expenditure, facilitating the adoption of advanced endoscopic technologies. Asia-Pacific countries are rapidly increasing their healthcare budgets, focusing on modernizing medical facilities and equipment.

Buy a Single-User PDF of Gastrointestinal Endoscopic Devices Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/5880

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

6. Competitive Landscape

7. Gastrointestinal Endoscopic Devices Market by Type

8. Gastrointestinal Endoscopic Devices Market by End Use

9. Regional Analysis

10. Company Profiles

11. Use Cases and Best Practices

12. Conclusion

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@snsinsider.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.